Portal de Periódicos da CAPES

Glycaemic control in stroke victims

2013; Elsevier BV; Volume: 24; Linguagem: Inglês

10.1016/j.ejim.2013.08.128

1879-0828

Daniel Vasquez Miranda, C. Rozeira, Tiago Gregório, Ludovina Paredes, Joaquim Pinheiro, Miguel Veloso, Denise Gonçalves Moura Pinheiro, Vítor Paixão Dias,

Acute Ischemic Stroke Management

Type 2 diabetes mellitus is a common cause of morbidity and mortality, because of its microvascular and macrovascular complications, decreasing life expectancy. According to the WHO, stroke is the second leading cause of death worldwide. Since it's one of type 2 diabetes complications, glycemic control could be of importance in its prevention. Objective: Analyse glycemic values of stroke onset at admission and determine the patients' final outcome from a functional point of view. Methods: Retrospective study of patients admitted at our stroke unit in 2012 with previously diagnosed and treated type 2 diabetes. Final outcome was assessed using Rankin scale and separating it into 3 groups (≤2; 3–5 and 6). Rankin score ≤2 was considered non-disabled at discharge. Results: 145 patients were admitted at our stroke unit with previously diagnosed type 2 diabetes. Mean age was 71 years (+/−6.1) with 57% male population. Patients with Rankin ≤2 had a mean glycemic value at admission of 161 mg/dL and a glycated haemoglobin of 7.3%. In patients with Rankin 3–5 it was respectively 184 mg/dL and 7.7%. Finally at Rankin 6 it was 219 mg/dL with a glycated haemoglobin of 8.2% (p = 0.03). Conclusions: Patients with a higher glycemic value at stroke onset had a worse outcome at discharge. Poor continuous glycaemic control seems to have a negative effect on short term recovery after a cerebrovascular event. This study shows a possibility to predict functional outcome in type 2 diabetes patients after a stroke, using instantaneous glycaemic values and glycated haemoglobin.